Quality of care for secondary cardiovascular disease prevention in 2009–2017: population-wide cohort study of antiplatelet therapy use in Scotland

<p><strong>Background:</strong>&nbsp;Antiplatelet therapy (APT) can substantially reduce the risk of further vascular events in individuals with established atherosclerotic cardiovascular disease (ASCVD). However, knowledge regarding the extent and determinants of APT use is li...

詳細記述

書誌詳細
主要な著者: Thalmann, I, Preiss, D, Schlackow, I, Gray, A, Mihaylova, B
フォーマット: Journal article
言語:English
出版事項: BMJ Publishing Group 2023

類似資料